Trials / Sponsors / Inspirna, Inc.
Inspirna, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Can Colorectal Cancer, Metastatic Colon Cancer | Phase 2 | 2023-10-10 |
| Completed | A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer Gastrointestinal Cancer, Gastrointestinal Neoplasms, Colorectal Cancer | Phase 1 | 2018-06-05 |
| Completed | A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer Endometrial Cancer, Endometrial Cancer Recurrent, Lung Cancer Recurrent | Phase 1 | 2016-11-01 |